Issue 6/2009

Depression symptoms and health-related quality of life among patients with metastatic breast cancer in programme of palliative cancer care (467 — 472)

L. SLOVACEK, B. SLOVACKOVA, I. SLANSKA, J. PETERA, P. PRIESTER, S. FILIP, J. KOPECKY

DOI: 10.4149/neo_2009_06_467

Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer (473 — 479)

M. ONDRUSOVA, D. ONDRUS, L. DUSEK, B. SPANIKOVA

DOI: 10.4149/neo_2009_06_473

Long-term survival of patients treated for Hodgkin’s disease in 1971–1996 depending on the clinical stage of the disease, patient’s fertility after therapy and cause of death analysis (480 — 485)

M. FRIDRICHOVA, Z. DIENSTBIER, M. LOUCKA, E. SKALA, E. BLOMANNOVA

DOI: 10.4149/neo_2009_06_480

Different phenotype manifestation of familial adenomatous polyposis in families with APC mutation at codon 1309 (486 — 489)

L. WACHSMANNOVA-MATELOVA, V. STEVURKOVA, Z. ADAMCIKOVA, V. HOLEC, V. ZAJAC

DOI: 10.4149/neo_2009_06_486

Cell cycle analysis and cytotoxic potential of Ruta graveolens against human tumor cell lines (490 — 493)

P. VARAMINI, M. SOLTANI, A. GHADERI

DOI: 10.4149/neo_2009_06_490

3-(5-Nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c]quinazoline induces ROS-mitochondrial mediated death signaling and activation of p38 MAPK in murine L1210 leukemia cells (494 — 499)

S. JANTOVA, A. REPICKY, L. CIPAK

DOI: 10.4149/neo_2009_06_494

Germline variants of the promyelocytic leukemia tumor suppressor gene in patients with familial cancer (500 — 507)

P. PLEVOVA, S. WALCZYSKOVA, I. JEZISKOVA, N. JURCKOVA, A. KREPELOVA, A. PUCHMAJEROVA, K. PAVLIKOVA, L. FORETOVA, J. ZAPLETALOVA, E. SILHANOVA

DOI: 10.4149/neo_2009_06_500

Immunophenotyping parameters as prognostic factors in T-acute leukemia patients (508 — 513)

O. BABUSIKOVA, L. STEVULOVA, M. FAJTOVA

DOI: 10.4149/neo_2009_06_508

Activation of HLA-G expression by 5-aza-2´- deoxycytidine in malignant hematopoetic cells isolated from leukemia patients (514 — 520)

K. POLAKOVA, E. BANDZUCHOVA, F. A. SABTY, M. MISTRIK, L. DEMITROVICOVA, G. RUSS

DOI: 10.4149/neo_2009_06_514

Hormonal and metabolic evaluation of adrenal incidentalomas (521 — 525)

H. WAGNEROVA, D. DUDASOVA, I. LAZUROVA

DOI: 10.4149/neo_2009_06_521

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance (526 — 532)

L. KOVAROVA, I. BURESOVA, T. BUCHLER, R. SUSKA, L. POUR, L. ZAHRADOVA, M. PENKA, R. HAJEK

DOI: 10.4149/neo_2009_06_526

Expression of Notch1, Jagged1 and β-catenin and their clinicopathological significance in hepatocellular carcinoma (533 — 541)

M. WANG, L. XUE, Q. CAO, Y. LIN, Y. DING, P. YANG, L. CHE

DOI: 10.4149/neo_2009_06_533

Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation (542 — 547)

V. ALTANEROVA, E. HORVATHOVA, M. MATUSKOVA, L. KUCEROVA, C. ALTANER

DOI: 10.4149/neo_2009_06_542

Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. (548 — 556)

L. HUNAKOVA, O. SEDLAKOVA, D. CHOLUJOVA, P. GRONESOVA, J. DURAJ, J. SEDLAK

DOI: 10.4149/neo_2009_06_548